While protection against SARS-CoV-2 infection is not that good, the Moderna Covid-19 vaccine does strongly prevent young children from having severe disease, being hospitalised and dying from the disease. — AFP
American biotech firm Moderna is pursuing regulatory approval for its Covid-19 vaccine in children under six years of age after the two-shot regimen was found to be safe and produced a strong immune response, the company said on Mac 23 (2022).
Specifically, two doses of 25mcg given to babies, toddlers and preschoolers, generated similar levels of antibodies to two doses of 100mcg given to young people aged 18-25, indicating that there would be similar levels of protection.
Already a subscriber? Log in.
Unlock 30% Savings on Ad-Free Access Now!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
